Published in J Immunol on June 15, 1987
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med (2003) 3.83
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun (2004) 3.29
NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med (2002) 3.26
Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci U S A (1989) 2.83
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A (2010) 2.30
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect Immun (1999) 1.76
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine (2012) 1.71
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect Immun (2005) 1.68
Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression. Infect Immun (1992) 1.67
Polyacrylamide gel electrophoresis of the capsular polysaccharides of Escherichia coli K1 and other bacteria. J Bacteriol (1988) 1.66
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein. Infect Immun (2008) 1.61
Review of meningococcal group B vaccines. Clin Infect Dis (2010) 1.58
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect Immun (1996) 1.54
Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev (2006) 1.53
Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J Bacteriol (1996) 1.50
NCAM polysialic acid can regulate both cell-cell and cell-substrate interactions. J Cell Biol (1991) 1.33
Vaccinology in the genome era. J Clin Invest (2009) 1.31
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect Immun (2002) 1.29
Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci U S A (1988) 1.28
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun (2010) 1.24
Genetic diversity and carriage dynamics of Neisseria lactamica in infants. Infect Immun (2005) 1.21
Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child (2003) 1.15
Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Infect Immun (1999) 1.14
Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes. Genome Biol (2007) 1.08
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis (2007) 1.08
Intercellular space is affected by the polysialic acid content of NCAM. J Cell Biol (1992) 1.08
The immunopathogenesis of meningococcal disease. J Clin Pathol (2003) 1.07
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I). Hum Vaccin Immunother (2014) 1.06
Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa. J Bacteriol (1992) 1.06
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines. Clin Vaccine Immunol (2012) 1.06
Bexsero® chronicle. Pathog Glob Health (2014) 1.05
Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine. Infect Immun (1997) 1.02
Regulation and activity-dependence of N-cadherin, NCAM isoforms, and polysialic acid on chick myotubes during development. J Cell Biol (1993) 0.99
Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc Natl Acad Sci U S A (1992) 0.98
Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis. J Clin Microbiol (1995) 0.98
Common cleavage pattern of polysialic acid by bacteriophage endosialidases of different properties and origins. J Virol (1989) 0.95
A common gene pool for the Neisseria FetA antigen. Int J Med Microbiol (2008) 0.95
Current status of meningococcal group B vaccine candidates: capsular or noncapsular? Clin Microbiol Rev (1994) 0.94
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine. BMC Microbiol (2014) 0.93
Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C. J Immunol (2009) 0.93
Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody. Proc Natl Acad Sci U S A (2014) 0.92
The meningococcus tamed? Arch Dis Child (2002) 0.92
Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity. Infect Immun (2002) 0.91
Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity. PLoS One (2012) 0.89
Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci. Infect Immun (2011) 0.88
Metabolism of vertebrate amino sugars with N-glycolyl groups: resistance of α2-8-linked N-glycolylneuraminic acid to enzymatic cleavage. J Biol Chem (2012) 0.87
N-acetyl-D-neuraminic acid lyase generates the sialic acid for colominic acid biosynthesis in Escherichia coli K1. Biochem J (1996) 0.87
Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies. Infect Immun (2006) 0.87
Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine. Infect Immun (2001) 0.85
Blastemal cells of nephroblastomatosis complex share an onco-developmental antigen with embryonic kidney and Wilms' tumor. An immunohistochemical study on polysialic acid distribution. Am J Pathol (1988) 0.85
Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB. Microbiology (2008) 0.84
Mutant bacteriophage with non-catalytic endosialidase binds to both bacterial and eukaryotic polysialic acid and can be used as probe for its detection. Glycoconj J (2001) 0.84
Structure of the C-terminal domain of Neisseria heparin binding antigen (NHBA), one of the main antigens of a novel vaccine against Neisseria meningitidis. J Biol Chem (2011) 0.83
Neisserial immunoglobulin A1 protease induces specific T-cell responses in humans. Infect Immun (2002) 0.83
Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications. Clin Vaccine Immunol (2006) 0.82
Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proc Natl Acad Sci U S A (2011) 0.81
Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents. Hum Vaccin Immunother (2015) 0.80
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme. PLoS One (2015) 0.80
Crystal structure analysis of the polysialic acid specific O-acetyltransferase NeuO. PLoS One (2011) 0.80
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. Hum Vaccin Immunother (2015) 0.79
Protein-linked glycans in periodontal bacteria: prevalence and role at the immune interface. Front Microbiol (2013) 0.79
The Long Road to an Effective Vaccine for Meningococcus Group B (MenB). Ann Med Surg (Lond) (2013) 0.78
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II). Hum Vaccin Immunother (2014) 0.78
T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease. Infect Immun (2005) 0.78
Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III. Vaccine (2012) 0.78
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries. PLoS One (2016) 0.77
Protein Crystallography in Vaccine Research and Development. Int J Mol Sci (2015) 0.77
Human Meningitis-Associated Escherichia coli. Ecosal Plus (2016) 0.76
Biochemical conditions for the production of polysialic acid by Pasteurella haemolytica A2. Glycoconj J (1998) 0.76
Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide. Infect Immun (1998) 0.76
Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B. Infect Immun (2005) 0.75
Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy. Hum Vaccin Immunother (2013) 0.75
Meningococcal B Vaccination (4CMenB) in Infants and Toddlers. J Immunol Res (2015) 0.75
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature (1999) 3.77
Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol (1984) 3.16
Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development (1997) 2.91
The bHLH protein NEUROGENIN 2 is a determination factor for epibranchial placode-derived sensory neurons. Neuron (1998) 2.87
Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun (1983) 2.87
Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature (1984) 2.78
Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect Immun (1986) 2.62
NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci U S A (1985) 2.49
Occurrence of alpha 2-8 linked polysialosyl units in a neural cell adhesion molecule. Biochem Biophys Res Commun (1983) 2.48
Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol (1982) 2.47
Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology (1993) 2.27
Molecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli. J Bacteriol (1986) 2.23
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol (1985) 2.18
Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J Biol Chem (1982) 2.09
Adult and embryonic mouse neural cell adhesion molecules have different binding properties. Nature (1983) 2.04
Complement-dependent B-cell activation by cobra venom factor and other mitogens? J Exp Med (1974) 1.97
Tissue- and developmental stage-specific forms of a neural cell surface antigen linked to differences in glycosylation of a common polypeptide. EMBO J (1982) 1.92
The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development (1993) 1.87
The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett (1976) 1.84
Isolation and nucleotide sequence of mouse NCAM cDNA that codes for a Mr 79,000 polypeptide without a membrane-spanning region. EMBO J (1987) 1.83
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry (1970) 1.81
Molecular forms of N-CAM and its RNA in developing and denervated skeletal muscle. J Cell Biol (1986) 1.79
In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur J Immunol (1976) 1.78
Phosphatidylinositol is involved in the membrane attachment of NCAM-120, the smallest component of the neural cell adhesion molecule. EMBO J (1986) 1.77
Differential exon usage involving an unusual splicing mechanism generates at least eight types of NCAM cDNA in mouse brain. EMBO J (1989) 1.76
Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron (1993) 1.74
Biosynthesis of enterobacterial common antigen. J Bacteriol (1985) 1.72
Studies on the transmembrane disposition of the neural cell adhesion molecule N-CAM. A monoclonal antibody recognizing a cytoplasmic domain and evidence for the presence of phosphoserine residues. Eur J Biochem (1984) 1.71
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J Biol Chem (1985) 1.71
Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A. J Immunol (1974) 1.69
Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol (1973) 1.68
The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics (1990) 1.67
Polyacrylamide gel electrophoresis of the capsular polysaccharides of Escherichia coli K1 and other bacteria. J Bacteriol (1988) 1.66
Glial cells express N-CAM/D2-CAM-like polypeptides in vitro. Nature (1985) 1.66
Isolation of mouse N-CAM-related cDNA: detection and cloning using monoclonal antibodies. EMBO J (1985) 1.64
Evidence for a specific monoamine oxidase associated with sympathetic nerves. Neuropharmacology (1971) 1.64
Molecular heterogeneity and structural evolution during cerebellar ontogeny detected by monoclonal antibody of the mouse cell surface antigen BSP-2. Brain Res (1983) 1.64
Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron (1997) 1.63
Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr Top Microbiol Immunol (1985) 1.63
Studies on the transmembrane disposition of the neural cell adhesion molecule N-CAM. The use of liposome-inserted radioiodinated N-CAM to study its transbilayer orientation. Eur J Biochem (1984) 1.63
Monoclonal antibody against cell surface glycoprotein of neurons. Brain Res (1981) 1.62
Expression of the Escherichia coli K5 capsular antigen: immunoelectron microscopic and biochemical studies with recombinant E. coli. J Bacteriol (1990) 1.61
Interaction of C3b, B, and D in the alternative pathway of complement activation. J Immunol (1975) 1.55
Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest (1991) 1.55
Selective expression of the 180-kD component of the neural cell adhesion molecule N-CAM during development. J Cell Biol (1985) 1.52
Mouse Otlx2/RIEG expression in the odontogenic epithelium precedes tooth initiation and requires mesenchyme-derived signals for its maintenance. Dev Biol (1997) 1.51
Differential splicing and alternative polyadenylation generates distinct NCAM transcripts and proteins in the mouse. EMBO J (1988) 1.50
Neural surface antigens during nervous system development. Cold Spring Harb Symp Quant Biol (1983) 1.50
Expression of Ia antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett (1983) 1.48
Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development (1998) 1.48
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Interactions between Mycoplasma pneumoniae and guinea pig complement. Infect Immun (1975) 1.47
Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J Infect Dis (1995) 1.47
Control of hindbrain motor neuron differentiation by the homeobox gene Phox2b. Development (2000) 1.46
Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun (1986) 1.46
Differential expression of mouse neural cell-adhesion molecule (N-CAM) mRNA species during brain development and in neural cell lines. J Neurosci (1986) 1.46
Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res (1990) 1.46
Preparation and fractionation of glycopeptides. Methods Enzymol (1982) 1.45
DNP-antigens activate the alternate pathway of the complement system. J Immunol (1974) 1.44
Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes. J Immunol (1974) 1.44
Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. Infect Immun (2005) 1.42
Barx1, a new mouse homeodomain transcription factor expressed in cranio-facial ectomesenchyme and the stomach. Mech Dev (1995) 1.42
Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci (2000) 1.41
The mouse neuronal cell surface protein F3: a phosphatidylinositol-anchored member of the immunoglobulin superfamily related to chicken contactin. J Cell Biol (1989) 1.40
The neural cell adhesion molecule L1 is distinct from the N-CAM related group of surface antigens BSP-2 and D2. EMBO J (1984) 1.40
Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain. J Biol Chem (1986) 1.40
Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system. J Immunol (1975) 1.39
Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol (1991) 1.38
NCAM is essential for axonal growth and fasciculation in the hippocampus. Mol Cell Neurosci (1997) 1.37
The SpeB virulence factor of Streptococcus pyogenes, a multifunctional secreted and cell surface molecule with strepadhesin, laminin-binding and cysteine protease activity. Mol Microbiol (2001) 1.37
Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11. J Cell Biol (1986) 1.37
Biosynthesis, membrane association, and release of N-CAM-120, a phosphatidylinositol-linked form of the neural cell adhesion molecule. J Cell Biol (1987) 1.36
Identification of positive and negative regulatory elements governing cell-type-specific expression of the neural cell adhesion molecule gene. Mol Cell Biol (1990) 1.34
Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. J Immunol (1982) 1.32
Genus-specific epitope on the 60-kilodalton Legionella heat shock protein recognized by a monoclonal antibody. J Clin Microbiol (1991) 1.30
Alternative splicing in the neural cell adhesion molecule pre-mRNA: regulation of exon 18 skipping depends on the 5'-splice site. Genes Dev (1991) 1.28
Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci U S A (1988) 1.28
Mice deficient in the polysialyltransferase ST8SiaIV/PST-1 allow discrimination of the roles of neural cell adhesion molecule protein and polysialic acid in neural development and synaptic plasticity. J Neurosci (2000) 1.26
Complete sequence and in vitro expression of a tissue-specific phosphatidylinositol-linked N-CAM isoform from skeletal muscle. Development (1988) 1.26
The Phox2b transcription factor coordinately regulates neuronal cell cycle exit and identity. Development (2000) 1.25
Novel cell-binding activity specific for N-acetyl-D-glucosamine in an Escherichia coli strain. FEBS Lett (1983) 1.25
Neural cell adhesion molecules during embryonic induction and development of the kidney. Development (1988) 1.25
Novel mannitol-containing oligosaccharides obtained by mild alkaline borohydride treatment of a chondroitin sulfate proteoglycan from brain. J Biol Chem (1979) 1.23
Characterization of murine bone marrow and spleen-derived stromal cells: analysis of leukocyte marker and growth factor mRNA transcript levels. Blood (1989) 1.22
Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency. Immunology (1975) 1.22
A surface marker for murine vascular endothelial cells defined by monoclonal antibody. J Histochem Cytochem (1982) 1.21
Neuroectoderm-associated antigens on Ewing's sarcoma cell lines. Cancer Res (1987) 1.21
Long-term but not short-term plasticity at mossy fiber synapses is impaired in neural cell adhesion molecule-deficient mice. Proc Natl Acad Sci U S A (1998) 1.21
Inherited polymorphism of guinea pig factor B and C4: evidence for genetic linkage between the C4 and Bf loci. J Immunol (1977) 1.19
The poly(glycosyl) chains of glycoproteins. Characterisation of a novel type of glycoprotein saccharides from human erythrocyte membrane. Eur J Biochem (1978) 1.18